Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Melanoma

  Free Subscription


1 Am J Dermatopathol
1 Biochem Biophys Res Commun
1 Cancer Lett
1 Gene
1 Int J Cancer
1 J Cell Physiol
3 J Immunother
1 J Invest Dermatol
2 Melanoma Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Dermatopathol

  1. LANG UE, Love NR, Cheung C, McCalmont TH, et al
    Use of the Ciliation Index to Distinguish Invasive Melanoma From Associated Conventional Melanocytic Nevi.
    Am J Dermatopathol. 2019 May 22. doi: 10.1097/DAD.0000000000001459.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  2. YANG X, Zhao H, Yang J, Ma Y, et al
    MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect.
    Biochem Biophys Res Commun. 2019 May 22. pii: S0006-291X(19)30997.
    PubMed     Text format     Abstract available

    Cancer Lett

  3. LI Y, Acharya G, Elahy M, Xin H, et al
    The Anthelmintic Flubendazole Blocks Human Melanoma Growth and Metastasis and Suppresses Programmed Cell Death Protein-1 and Myeloid-Derived Suppressor Cell Accumulation.
    Cancer Lett. 2019 May 22. pii: S0304-3835(19)30321.
    PubMed     Text format     Abstract available


  4. WANG S, Wu Y, Xu Y, Tang X, et al
    miR-10b promoted melanoma progression through Wnt/beta-catenin pathway by repressing ITCH expression.
    Gene. 2019 May 23. pii: S0378-1119(19)30520-7. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available

    Int J Cancer

  5. OROUJI E, Federico A, Larribere L, Novak D, et al
    Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Int J Cancer. 2019 May 27. doi: 10.1002/ijc.32432.
    PubMed     Text format     Abstract available

    J Cell Physiol

  6. YU H, Ma M, Wang X, Zhou Z, et al
    Propofol suppresses proliferation, invasion, and migration of human melanoma cells via regulating microRNA-137 and fibroblast growth factor 9.
    J Cell Physiol. 2019 May 27. doi: 10.1002/jcp.28896.
    PubMed     Text format     Abstract available

    J Immunother

  7. AFZAL MZ, Sarwar T, Shirai K
    Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors.
    J Immunother. 2019 May 28. doi: 10.1097/CJI.0000000000000272.
    PubMed     Text format     Abstract available

  8. GAMBICHLER T, Schroter U, Hoxtermann S, Susok L, et al
    A Brief Communication on Circulating PD-1-positive T-Regulatory Lymphocytes in Melanoma Patients Undergoing Adjuvant Immunotherapy With Nivolumab.
    J Immunother. 2019 May 28. doi: 10.1097/CJI.0000000000000277.
    PubMed     Text format     Abstract available

  9. BISSCHOP C, Wind TT, Blank CU, Koornstra RHT, et al
    Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program.
    J Immunother. 2019 May 28. doi: 10.1097/CJI.0000000000000271.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  10. KOOPMANS I, Hendriks MAJM, van Ginkel RJ, Samplonius DF, et al
    Bispecific antibody approach for improved melanoma-selective PD-L1 immune checkpoint blockade.
    J Invest Dermatol. 2019 May 22. pii: S0022-202X(19)31565.
    PubMed     Text format     Abstract available

    Melanoma Res

  11. YANG J, Price MA, Wanshura LEC, He J, et al
    Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain.
    Melanoma Res. 2019 Feb 1. doi: 10.1097/CMR.0000000000000574.
    PubMed     Text format     Abstract available

  12. ZULEGER CL, Newton MA, Ma X, Ong IM, et al
    Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from metastatic melanoma patients.
    Melanoma Res. 2019 May 23. doi: 10.1097/CMR.0000000000000625.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.